title: [The clinical efficacy of plasmosorption in stenocardia].
abstract: Follow-up examinations of 52 anginal patients who have received combined treatment involving plasma sorption indicate a good response in 77%, satisfactory in 11.5% and no response in 11.5% of the examinees. Exercise tolerance and performance increased by 34.3 and 52.1%, respectively. The scope of chemotherapy was related to the initial severity of the disease. Clinical remission after plasma sorption lasted 8.4 +/- 0.7 months.
authors.forename: A N
authors.initials: AN
authors.lastname: Fomichev
authors.forename: A N
authors.initials: AN
authors.lastname: Fedoseev
authors.forename: A A
authors.initials: AA
authors.lastname: Narynskiĭ
mesh_terms: D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000628:therapy*; D003131:Combined Modality Therapy; D003692:Delayed-Action Preparations; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000008:administration & dosage; D010949:Plasma; D016060:Sorption Detoxification / Q000379:methods*; D013607:Tablets
chemical_list: D003692:Delayed-Action Preparations; D013607:Tablets; D005996:Nitroglycerin
vernacular_title: Klinicheskaia éffektivnost' plazmosorbtsii pri stenokardii.